THE introduction of catheters for the treatment of seriously ill patients has been one of the most important advances in medicine in recent years. However, the risk of infection to the patient through ...

A study published in Clinical Infectious Diseases examined the cost-effectiveness of antimicrobial locks for the prevention of central line-associated bloodstream infections. Antibiotic lock therapy ...

Despite the development of preventive measures to reduce risks of infection related to CVC insertion and maintenance, CLABSI continues to be a significant burden in pediatric populations. Current ...

Antimicrobial lock solutions are effective in reducing by 69% the risk for catheter-associated bloodstream infections, which, according to a study, are the most costly infections in healthcare.

CRANFORD, N.J., Jan. 2, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and ...

Citius Pharmaceuticals, Inc. (CTXR) is a specialty pharmaceutical company focused on the development and commercialization of proprietary formulations of already-approved drugs which target large and ...

CRANFORD, N.J., June 8, 2021 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of ...

Please provide your email address to receive an email when new articles are posted on . “Our goal in this study was to evaluate whether an antibiotic timeout by frontline clinicians after 3 to 5 days ...

The successful treatment of intraabdominal infection requires a combination of anatomical source control and antibiotics. The appropriate duration of antimicrobial therapy remains unclear. We randomly ...

Please provide your email address to receive an email when new articles are posted on . Traditionally, initial antimicrobial therapy for immediately life-threatening infections was administered ...